Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abnormal tissues
01
Overview
The term "abnormal tissues" refers to any tissue in the body that presents histological or molecular features deviating from normal, usually due to diseases such as cancer or injury. It is used generically to describe tissue changes seen in pathology, including uncontrolled growth, changes in cellular morphology, and loss of normal tissue architecture[3][7]. "Abnormal tissue" is not a molecular target, receptor, or protein, and should not be classified as such. Instead, it is a broad category encompassing a wide range of tissue alterations, each with distinct molecular pathology and therapeutic targets[1][2][3][5][7].
- Other names
- Pathological tissueDiseased tissueNeoplastic tissueTumor tissueLesional tissue
Beyond the preview
Go deeper on Abnormal tissues.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abnormal tissues.